Anti-Cyanide Drugs.

Abstract

Both metal ion complexes and unsaturated organic compounds are being explored as potential in vivo anti-cyanide drugs. Certain water soluble metalloporphyrins containing cobalt (III), silver (II), chromium (II), rhodium (III), palladium (II), or iron (III), and cobalt (II), and (III) sulfonated phthalocyanines have been shown to rapidly complex cyanide at physiological pH. Detailed kinetic work indicates than both cyanide and HCN are reactants. A number of five, six and seven membered ring systems with activated double bonds known as alkylidenes have been shown to complex cyanide. Kinetic work indicates a rate law first order in each reactant, then a following cyanide independent rearrangement, forming a low molecular weight covalently bound cyanide species, with the loss of water and carbon dioxide. Twenty such drugs have been synthesized. Keywords: Antidotes; Therapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 1986
Accession Number
ADA185962

Entities

People

  • Peter Hambright

Organizations

  • Howard University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Biomedical Research
  • Carbon Dioxide
  • Carboxylic Acids
  • Chelate Compounds
  • Chemical Synthesis
  • Chemistry
  • Chromium
  • Coordination Complexes
  • Electron Density
  • Electrons
  • Hemoglobin
  • Metals
  • Molecules
  • Organic Chemistry
  • Organic Compounds
  • Phthalocyanines
  • Transition Metals

Fields of Study

  • Chemistry

Readers

  • Organic Chemistry